Galapagos Biopharma Denmark ApS — Credit Rating and Financial Key Figures

Galapagos Biopharma Denmark ApS (CVR number: 42447242) is a company from KØBENHAVN. The company recorded a gross profit of 11.8 mDKK in 2023. The operating profit was 1775.7 kDKK, while net earnings were 1389.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was 15.4 %, which can be considered excellent and Return on Equity (ROE) was 53.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 44.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Galapagos Biopharma Denmark ApS's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.